These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4520357)

  • 1. Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment.
    Kreek MJ
    N Y State J Med; 1973 Dec; 73(23):2773-7. PubMed ID: 4520357
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone-methadone combination for the treatment of opiate dependence.
    Parwatikar S; Knowles RR
    Proc Natl Conf Methadone Treat; 1973; 2():1350-4. PubMed ID: 4612373
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 4. The oral absorption of methadone from a new parenterally nonabusable tablet.
    Van Harken DR; Monteleone P; Caruso FS; Bloom WA
    Proc Natl Conf Methadone Treat; 1973; 2():1355-61. PubMed ID: 4808288
    [No Abstract]   [Full Text] [Related]  

  • 5. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicologic findings in six fatalities involving methadone.
    Garriott JC; Sturner WQ; Mason MF
    Clin Toxicol; 1973; 6(2):163-73. PubMed ID: 4715200
    [No Abstract]   [Full Text] [Related]  

  • 7. Methadone plasma levels in maintenance patients: the effect of dose omission.
    Verebely K; Kutt H
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):373-86. PubMed ID: 1153882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release methadone salts and methadone-naloxone mixtures. Part 2: In vitro studies of methadone release.
    Choulis NH; Sandhu BS; Abellana-Intaphan LA
    Pharmazie; 1977 May; 32(5):287-8. PubMed ID: 561410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone in the management of heroin addiction.
    Med Lett Drugs Ther; 1972 Mar; 14(5):13-5. PubMed ID: 4669864
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
    Calsyn DA; Malcy JA; Saxon AJ
    J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of level of anxiety, depression and hostility with methadone plasma concentration in opioid-dependent patients receiving methadone on a maintenance dosage schedule.
    Blake DA; Distasio C
    Proc Natl Conf Methadone Treat; 1973; 2():1308-16. PubMed ID: 4808284
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Efficacy and side effects of three widely different methadone doses.
    Goldstein A; Judson BA
    Proc Natl Conf Methadone Treat; 1973; 1():21-44. PubMed ID: 4612369
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological correlates of methadone maintenance pharmacotherapy.
    Kreek MJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone plasma level: sustained by a reservoir of drug in tissue.
    Dole VP; Kreek MJ
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):10. PubMed ID: 4509643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.